Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Mundipharma Research GmbH & Co KG

ClinicalTrials.gov Identifier:

NCT00412100

First received: December 14, 2006

Last updated: August 9, 2012

Last verified: August 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	September 2008
Primary Completion Date:	July 2008 (Final data collection date for primary outcome measure)

No publications provided by Mundipharma Research GmbH & Co KG

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Löwenstein O, Leyendecker P, Lux EA, Blagden M, Simpson KH, Hopp M, Bosse B, Reimer K. Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials. BMC Clin Pharmacol. 2010 Sep 29;10:12.

To Top